Introduction: Variation of doses due to positional uncertainties of applicators based on orthogonal radiograph has been evaluated by several researchers. The present study has analyzed the various possibilities of special alterations of applicator placements in intracavitary brachytherapy (ICBT) and its impact on the dose to target volume, rectum, and bladder. An innovative approach has been suggested to quantify and utilize the special coordinates for reproducibility of applicator based on the pelvic bone landmark.
INTRODUCTION
Brachytherapy remains the mainstay for treatment of carcinoma cervix either alone or in combination with external beam radiotherapy. The treatment planning for intracavitary brachytherapy (ICBT) has evolved from orthogonal radiograph based two-dimensional (2D) planning to image-guided computed tomography (CT)/magnetic resonance imaging based three-dimensional (3D) planning. This development has opened possibilities for objective target volume delineation, organs at risk (OAR) delineations, and the eventual establishment of correlation of treatment response and toxicities. Several publications [1] [2] [3] have advocated that positioning and reproducibility of applicator placement are essential to obtain improved local control, survival, and lower morbidity. International Commission on Radiation Units (ICRU) report 38 [1] enumerate various aspects of ICBT starting from the insertion of applicators, its positioning with respect to certain anatomical landmarks, dose prescription, and evaluation of dose to critical structures based on bone anatomy. Further ICRU 89 [4] has recommended the use of volume-based evaluation of ICBT treatment plans for target volume and OAR's. The rectum, bladder, sigmoid colon, bowl loops, and lymphatic trapezoid are various organs adjacent to the target volume which require careful and well-calibrated dose constraints. Pop and Nagy, [5] in 2016, presented a review of 34 English language articles written in the past 10 years and analyzed physics perspective in ICBT in cervical cancer and concluded that the use of CT in brachytherapy planning has already proved its benefits. Regarding costs, 3D brachytherapy has been proven to be expensive but in the future, the standard would be image guided external radiotherapy and brachytherapy with plan summation. This could not be done without dose volume histogram analysis in brachytherapy and specific information about the dose to the OAR's. Various researchers also pointed out the variation of doses due to positional uncertainties in 2D, i.e., for applications based on orthogonal radiographs. However, it is clearly understood that even with rigorous 2D/3D treatment planning the positional inaccuracies in the placement and orientations of applicator arising due to tumor topology or other anatomical restrictions could not be compensated with optimization of dwell points and dwell times. The present study attempts to analyze the various possibilities of variations in placing the applicators in ICBT and its impact on the dose to rectum and bladder points and other OAR.
An innovative approach has been suggested to quantify the special coordinates for reproducibility of applicator based on pelvic bone structure.
MATERIALS AND METHODS
Twenty-seven fractions of ICBT applications were done at our institution between 2014 and 2016 have been included in this retrospective study. All the applications were done under the general anesthesia and image guidance was obtained with the help of C arm (Allengers Medical System Ltd., Chandigarh, India). A volume of 7 ml of radiopaque dye (1:4 dilutions) was filled in the balloon of a Foley's catheter. Anteroposterior and lateral scanograms were obtained in each fraction. CT scan (Siemens Healthcare GmbH Henkestr. 127, 91052 Erlangen, Germany) was performed to ascertain the position of the applicators and 3 mm slices were generated on CT scanner. A specialized scan protocol was followed for better visualization of the applicator while minimizing the number of CT slices. The imaged area extended from 2 cm above the tip of the applicator to 5 cm below the inferior surface of the ovoids to ensure the entire bladder was included in the imaged area. During image acquisition and treatment, the bladder was continuously drained through the indwelling catheter and rectal retractors were inserted to keep the rectum as distal as possible. The image data set of CT scan was transferred through DICOM 3.0 protocol for treatment planning. The target and OARs were delineated as per ICRU 38 [1] and GEC-ESTRO [6] [7] [8] [9] protocols. The treatment planning was performed on Oncentra MasterPlan v4.3 (Nucletron Asia Pacific Ltd., Amsterdam, The Netherlands) in accordance with the ICRU 38 [1] recommendations. The tip of the applicators and its angulations were measured from top of the pubic symphysis.
Treatment planning
In this study, Asia Pacific fletcher suite applicators having intrauterine tubes with angulations of 15° and 30° and vaginal ovoid's of different diameters in conformity with anatomical needs have been utilized. All the three catheters were reconstructed and origin of the application was marked at center of the top of the flange. Bladder and rectum points were marked as per the ICRU 38 recommendations. Right and left applicator points A1 and A2 were identified 2 cm superior and 2 cm lateral to the OS point. Three points were marked on proximal wall of Bladder balloon each at the superior, mid, and inferior positions which were identified as bladder points. Similarly, number of points was created at the proximal wall of the rectum in various transverse sections and defined as rectal points. The applicators were aligned along the central tandem. After defining the dwell positions for each applicator and prescription the dose were normalized for 100% at applicator points. There was no optimization of dwell time. After minor alterations in dwell positions, the treatment plan thus generated was evaluated. The point having maximum dose was considered for the evaluation of complication to OARs. For the consecutive fraction of the treatment first fraction was considered as reference in terms of dwell positions, dose to bladder, and rectum points. Along with this, the study focused on an innovative approach and four possibilities which may be the measure of deviation of the spatial orientations application from standard. These deviations may be finally accountable for dose variation to rectum and bladder. The pertinent details are as under. a. The angle between the line joining the applicator points A1 and A2 through the tip of the central tandem was defined as angle α [ Figure 1 ] b. The angle between A1 and A2 with respect to the head of the sacrum defined as angle β [ Figure 2 ] c. The angle of applicator point with respect to pelvic bone in coronal slices defined as angle γ [ Figure 3 ] d. The distance of each applicator from the flat couch top was taken as X, Y, and Z, respectively [ Figure 4 ].
For each fraction above mentioned, four parameters were recorded and tabulated for further analysis.
RESULTS AND DISCUSSION
The planning data were transferred to the excel worksheet for further analysis. A graphical representation was generated for each application condition used in the study with the help of excel program. These graphs are presented in Figures 5-10 . A linear trend line was generated for each graph and the trend line (standard equation of line Y = mX + C; m is slope of the line and C is the constant) were having a slope and quantification of statistical relationship between two series of events in terms of R 2 , and excel worksheet uses the R 2 formula to find the correlation between two variables. The mean angle between the two applicator points with respect to the tip of central tandem [ Table 1 ] is 62.24° ± 14.26° and it ranged from (42.80° to 92.70°). The plot of same angle for its relation with dose to bladder and rectum [ Figure 5 ], the bladder dose trend line was found to be y = 0.0559 X + 3.4727 with R 2 = 0.1089 and rectum dose trend line y = 0.0198 X + 4.6903 with R 2 = 0.0287 which is clear indication of increase of bladder dose. The mean angle between applicator points with junction point situated on the sacrum bone was found to be 37.13° ± 5.64° [ Table 2 ] ranging from 27.90° to 50.15°. The dose to bladder decreased substantially with an increase in this angle [ Figure 6 ]. As far as dose to the rectum is concerned, it remained almost unaffected. This can be predicted from the trend lines y = −0.0435 X + 4.8658, R 2 = 0.0657 and y = 0.0096 X + 4.8372, R 2 = 0.0068 for bladder and rectum, respectively. The average inclinations between the line joining applicator points and a point defined on pelvic bone was found to be 105.51° ± 6.581° [ Table 3 ] and ranged from 93.00° to 119.50° the trend line for bladder and rectum is y = −0.0516 X + 4.9755, R 2 = 0.0928 and y = −0.0444 X + 5.593, R 2 = 0.143, respectively, which clearly indicates that bladder dose reduces significantly with increase in this particular angle and the rectum dose increases slightly [ Figure 7 ]. The mean distance of the tip of the central tandem from couch top is 11.17 ± 1.654 cm [ Table 4 ] and the trend line for bladder and rectum with respect to this is y = 0.0333 X + 3.7944, R 2 = 0.0388 and y = 0.0306 X + 4.5503, R 2 = 0.0682, respectively, which reveals about the increase in both bladder and rectum doses [ Figure 8 ]. The distance of left ovoid from couch top [ Table 5 ] was on an average 8.72 ± 1.20 cm and Table 6 ] averaged to 8.77 ± 1.19 cm and ranged from 6.00 to 10.60 cm. When these evaluations were correlated with the doses to bladder and rectum the trend line were 2.00 4.20 Mean (°) 37.13±5.64 y = 0.0521 X + 3.5273, R 2 = 0.0944 and y = 0.0346 X+ 4.4858, R 2 = 0.0869, respectively, and it has almost same effect on both, i.e., the dose to bladder as well as rectum [ Figures 9 and 10 ].
CONCLUSION
Kim et al. [2] evaluated geometric variations in multiple intracavitary applications for carcinoma of the cervix and reviewed effects of dosimetry based on orthogonal radiographs in patients treated with high-dose-rate (HDR) brachytherapy. They concluded that major variations between applications occurred more commonly in colpostats placement than in tandem placement. Rutten et al. [3] studied the Dose variation due to differences in applicator placement used for ICBT of cervical cancer based on orthogonal radiographs and concluded that less than optimum positioning may be caused by patient anatomy, selection of improper components for the insertion, or by movement of the tandem and ovoids during packing and the hypothesized that repositioning allows better dose distribution to the cervix and for better dose control to critical structures. Jones et al. [10] analyzed the need of simulation for each insertion of tandem and ovoid in multi fraction HDR intracavitary in carcinoma of the cervix and summarized that increased dose to OAR occurred when individualized treatment planning was not performed. They also advocated individualized treatment planning in HDR tandem and ovoid insertions for the treatment of cervix cancer. Changes in applicator positions and dose distribution between HDR brachytherapy fractions in cervix carcinoma patients were described by Garipağaoğlu et al. [11] and suggested that proper.
Treatment planning, dose calculation, and optimization according to normal tissue doses for each fraction are necessary in cervical carcinoma patients receiving HDR brachytherapy using tandem and ovoids. Davidson et al. [12] explained the need of image-guided cervix HDR brachytherapy treatment planning using custom CT planning for each insertion which provides a better conformal avoidance of OAR.
The present study evaluated the dose to the rectum and bladder with respect to the placement and orientations of applicators using CT simulations slices. It is evident from the trend line and analysis of results that a minor change in the positioning of the three applicators changes the position of the origin of the application and hence applicator based points definitions. This, in turn, changes the prescription/normalization point. The spatial change in the position of applicator points affects the dose to the OARs as the dose distribution for a particular application depends on the normalization point. The changes observed are as follows:
Dose to bladder points increases with increase in the angle between two applicator points as a result of a decrease in the treatment length of the central tandem, a distance of the tip of the central tandem, left ovoid, and right ovoid from the couch. There is a trend of decrease in bladder dose with an increase in the angle between applicator points with sacrum bone as joining point. The bladder point doses also decreased with increment in the angle of the line joining applicator points and a specific point on pelvic bone in the same coronal section. As per the trend lines for rectum doses, it increases with the increase in the distance of tip of applicators from the couch top whether it is central tandem or ovoids. The change was not much appreciable with other variations except its decrease with increase in the angle between applicator points with respect to sacrum bone. It may thus be safely concluded that optimal plans even with orthogonal radiographs could be generated by verifying the application based on the parameters discussed above and CT based plans could be utilized more effectively instead of playing optimization option or manual dwell times which is also in agreement of the study by Davidson et al. [12] In the situations where orthogonal radiograph-based or template-based ICBT is performed this study may generate a data set (nomograms) to have an optimal treatment plan even without 3D images. It provided a method for reproducibility of target volume and applicators in 3D using bone anatomy. This may be a suitable method to generate an alternative approach to develop prescription point which would be anatomy based rather than based on pull and push of the applicator and packing. A statistically significant study will throw more vital information the pilot study.
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